The mTORC2, a functional complex of mechanistic target of rapamycin (mTOR) together with the components mTOR, mLST8, Rictor, mSIN1, and Protor1/2, is regarded as apromising target for breast cancer therapy 10-13. The gene discussed is RICTOR; the disease is breast cancer.